Quantcast
Channel:
Viewing all articles
Browse latest Browse all 64049

FDA Approves OXYTROL® FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women

0
0
WHITEHOUSE STATION, N.J., Jan. 25, 2013 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved OXYTROL FOR WOMEN (oxybutynin transdermal system, 3.9 mg/day), the first and...

Viewing all articles
Browse latest Browse all 64049

Latest Images

Trending Articles





Latest Images